Nucleix Ltd. Company Profile, Contacts & Intelligence

Nucleix Ltd. Overview

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. Our non-invasive EpiCheck® platform delivers highly accurate and sensitive results, all while providing a seamless testing option for physicians, their patients and the healthcare system. Our first product, Bladder EpiCheck®, is CE-marked in Europe for primary and recurrent bladder and upper tract urinary cancer, and FDA 510(k) cleared in the U.S. for bladder cancer recurrence. It is commercially available in both regions. Our global team operates from San Diego, California in the US and Rehovot, Israel.

Headquarters

Il

Website

www.nucleix.com

Industry

Biotechnology Research

Stock Symbol

PHGE

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Nucleix Ltd. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Nucleix Ltd. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Nucleix Ltd. Workforce Composition

Seniority breakdown across 3 visible profiles.

Compare Similar Companies to Nucleix Ltd.

Explore companies in related markets and compare their industry and employee estimates.